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Abstract
Background: The mammalian target of rapamycin (mTOR) is a key regulator of mRNA translation
whose action can be inhibited by the drug rapamycin. Forms of long-term plasticity require protein
synthesis and evidence indicates that mRNA in dendrites, axon terminals and cell bodies is essential
for long-term synaptic plasticity. Specific to pain, shifts in pain thresholds and responsiveness are
an expression of neuronal plasticity and this likely contributes to persistent pain. We investigated
this by inhibiting the activity of mTOR with rapamycin at the spinal level, of rats that were subjected
to the formalin test, using both behavioural and electrophysiological techniques.
Results: For in vivo electrophysiology, Sprague Dawley rats were fully anaesthetised and single-
unit extracellular recordings were obtained from lamina V wide dynamic range (WDR) dorsal horn
spinal neurones at the region where input is received from the hind paw. Neuronal responses from
naive rats showed that rapamycin-sensitive pathways were important in nociceptive-specific C-fibre
mediated transmission onto WDR neurones as well mechanically-evoked responses since
rapamycin was effective in attenuating these measures. Formalin solution was injected into the hind
paw prior to which, rapamycin or vehicle was applied directly onto the exposed spinal cord. When
rapamycin was applied to the spinal cord prior to hind paw formalin injection, there was a significant
attenuation of the prolonged second phase of the formalin test, which comprises continuing
afferent input to the spinal cord, neuronal hyperexcitability and an activated descending facilitatory
drive from the brainstem acting on spinal neurones. In accordance with electrophysiological data,
behavioural studies showed that rapamycin attenuated behavioural hypersensitivity elicited by
formalin injection into the hind paw.
Conclusion: We conclude that mTOR has a role in maintaining persistent pain states via mRNA
translation and thus protein synthesis. We hypothesise that mTOR may be activated by excitatory
neurotransmitter release acting on sensory afferent terminals as well as dorsal horn spinal
neurones, which may be further amplified by descending facilitatory systems originating from higher
centres in the brain.
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The serine-threonine protein kinase mammalian target of
rapamycin (mTOR), which is inhibited by the immuno-
suppressant drug rapamycin regulates several intracellular
pathways in response to various extracellular signals,
nutrient availability, energy status of the cell and stress.
These pathways involve mTOR-dependent activation of
the 70 kDa ribosomal protein S6 kinase (p70S6K) as well
as the inactivation of the repressor of mRNA translation,
eukaryotic initiation factor 4E (eIF4E) binding protein
(4EBP) [1,2]. It is therefore not surprising that mTOR
activity is modified in a wide range of pathological states
such as cancer and neurodegenerative disorders such as
Alzheimer's disease [3,4].
Given its widespread implications, it would be logical to
hypothesise that rapamycin-sensitive pathways play
important roles in persistent pain-like states at the spinal
level. Elegant studies investigating the roles of rapamycin-
sensitive pathways on injury-induced hyperexcitability of
Aplysia axons [5]; the roles of local rapamycin-sensitive
pathways at the level of the hind paw in a model of nerve
injury [6] or the time-restricted roles of rapamycin-sensi-
tive pathways in hippocampal long term potentiation
(LTP) [7] reveal insights into the possible roles these
mechanisms play in the peripheral and central nervous
system. Our studies focus on the spinal mechanisms of
pain- an area that like the peripheral mechanisms of pain,
generates much interest for many research groups. How-
ever, to date, few have investigated the role of spinal pro-
tein synthesis pathways in persistent pain-like states.
Kim and colleagues have shown that protein synthesis is
an important component of the behavioural hypersensi-
tivity induced by injection of formalin into the hind paw
of mice. This was achieved by spinally administering the
general transcription inhibitor actinomycin D and the
general translation inhibitor anisomycin spinally, prior to
formalin injection into the hind paw. The result was an
attenuation of behavioural hypersensitivity when com-
pared to spinally administered saline [8]. More recently,
Price and colleagues have implicated specific spinal
mRNA translation pathways in formalin-induced behav-
ioural hypersensitivity [9]. Their studies focused on mice
lacking fragile × mental retardation gene (FMR1), which is
another protein that influences mRNA translation. FMR1
is also important for pain processing since it was found
that knock out mice displayed reduced formalin-induced
behavioural hypersensitivity compared to their wild type
littermates. Furthermore, spinal or hind paw administra-
tion of rapamycin was ineffective in attenuating formalin-
induced behavioural hypersensitivity in the FMR1 mutant
mice compared to their wild type littermates showing that
not only are rapamycin-sensitive pathways implicated in
persistent pain-like states, but that they also interact with
other mRNA translation pathways.
The formalin test was first presented by Dubuisson and
Dennis in 1977 [10] and is characterised by biphasic
ongoing neuronal excitability and behavioural hypersen-
sitivity, which are now commonly used as markers of
analgesic drug efficacy [11,12]. We show that rapid mRNA
translation mediated by mTOR at the spinal level is neces-
sary for the neuronal hyperexcitability as well as behav-
ioural hypersensitivity induced by formalin that is
injected into the hind paw of rats.
Results
Rapamycin attenuates baseline neuronal responses under 
physiological conditions
We used in vivo electrophysiology (see methods) to study
the effect of rapamycin on neuronal responses from naive
rats in order to determine the importance of rapamycin-
sensitive pathways under physiological conditions. When
rapamycin was administered onto the exposed spinal cord
(250 nM or 11.43 ng in 50 μl), there was a significant
reduction in nociceptive-specific C-fibre-mediated trans-
mission onto WDR neurones when compared to DMSO
control (Figure 1A), therefore indicating that rapamycin-
sensitive pathways mediate stimulus-evoked responses of
nocicpetors. We therefore expected that wind-up, which is
a potentiated response mediated by nociceptive C-fibre
activity and a measure of neuronal hyperexcitability,
would also be significantly inhibited. However, this was
not case, although in all cases, wind up was inhibited to
some extent. Furthermore, in some cases, there were
clearly strong inhibitory effects when compared to DMSO
(Figure 1B). Although this data my appear conflicting, one
must bear in mind that measuring the number of action
potentials attributable to C-fibres after a train of stimuli
does not directly correlate with wind up since wind up
involves the added feature of non linear recruitment of
initially silent NMDA receptors [13] which likely requires
a higher degree of inhibition achievable, assumingly by a
higher dose of rapamycin.
Rapamycin also significantly inhibited neuronal
responses to von Frey filaments (8 – 60 g) when compared
to DMSO (Figure 1C). Previous studies have shown that
in naive rats, the 50% behavioural mechanical withdrawal
threshold varies from around 11 to 19 g [14,15] so it is
apparent from these results that rapamycin-sensitive path-
ways are important in mediating neuronal responses to
innocuous as well as noxious mechanical stimuli under
physiological conditions. Rapamycin-sensitive pathways
appear to be more important in mechanically-evoked
responses since thermally-evoked responses were weakly
altered by rapamycin (Figure 1D). Therefore, although
rapamycin-sensitive pathways are important for stimulus-Page 2 of 10
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tions, this appears to only be true for specific sensory
modalities.
Rapamycin attenuates the second phase of formalin-
induced neuronal hyperexcitability
We used in vivo electrophysiology to study spinal neuro-
nal hyperexcitability induced by formalin injection into
the hind paw. When rapamycin was administered onto
the exposed spinal cord 3 min prior to formalin injection
into the hind paw, there was a significant reduction in
neuronal activity from 40 – 60 min when compared to
DMSO administration. Area under the curve (AUC) anal-
ysis confirmed that overall, rapamycin elicited a signifi-
cant reduction in the second phase of the formalin test
(Figure 2A). There were no significant effects of rapamycin
on the first phase of the formalin test. To confirm that
these effects were indeed due to inhibition of mRNA
translation, we also examined the effects of the general
mRNA translation inhibitor anisomycin, on the formalin
test in the same manner as that for rapamycin. There was
a strong trend for inhibition of neuronal hyperexcitability
Effects of spinally administered rapamycin onbaseline neuronal responsesFigure 1
Effects of spinally administered rapamycin onbaseline neuronal responses. A. C-fibre mediated transmission onto 
WDR neurones was significantly inhibited by rapamycin (n = 9) compared to DMSO (n = 10). B. In some cases, there were 
strong trends for inhibition (as shown in example) by rapamycin of wind up, yet overall, these changes were not significant. C. 
Rapamycin significantly inhibited responses to 8, 15, 26 and 60 g von Frey filaments when compared to DMSO. D. Rapamycin 
exerted a significant inhibitory effect on the responses evoked by 35°C. (A. 1 way ANOVA with repeated measures and Dun-
nett's post-tests. C and D. 2 way ANOVA with repeated measures and Bonferroni's post-tests, *P < 0.05, **P < 0.01, ***P < 
0.001).Page 3 of 10
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just like rapamycin, AUC analysis confirmed that overall,
anisomycin elicited a significant reduction in the second
phase of the formalin test (Figure 2B). A time of 3 min
incubation with rapamycin or anisomycin was chosen
due to direct evidence from studies on the importance of
rapamycin-sensitive pathways in hippocampal LTP point-
ing towards a time-restricted role for the involvement of
rapamycin-sensitive pathways at LTP induction [7]. Spinal
neurones selected for 25% DMSO and rapamycin treat-
ment or 10% DMSO and anisomycin treatment prior to
formalin being injected into the hind paw comprised
equivalent populations for all measures (Tables 1 and 2)
i.e. there was no selection bias for neurones for either
treatment.
Rapamycin attenuates formalin-induced behavioural 
hypersensitivity when administered 20 min before formalin
For behavioural studies, we first administered rapamycin
5 min prior to injecting formalin into the hind paw. We
found that unlike the results produced with in vivo elec-
trophysiology, there was no significant effect of rapamy-
cin on formalin-induced behavioural hypersensitivity
(data not shown). We assume this to be due to the differ-
ences in the experimental conditions since the in vivo
electrophysiology set up involves applying the drug
directly to the exposed spinal cord (dura removed)
whereas the behavioural studies involve injecting the drug
onto the surface of the cord (dura in tact). In addition, we
cannot rule out the possibility that the rats had com-
pletely recovered from anaesthesia within 5 min even
though they appeared to be fully alert. When rapamycin
was spinally administered 20 min prior to formalin injec-
tion into the hind paw, there was a significant reduction
Table 1: WDR neurones selected for DMSO or rapamycin 
treatment prior to hind paw formalin injection comprised equal 
populations for all measures
DMSO (n = 11) Rapamycin (n = 9)
Depth (μM) 777 ± 36 790 ± 51
Aβ-fibre threshold (μA) 0.27 ± 0.10 0.23 ± 0.11
C-fibre threshold (μA) 0.78 ± 0.17 0.55 ± 0.13
Aβ-fibre spikes 104 ± 9 104 ± 16
Aδ-fibre spikes 92 ± 18 93 ± 19
C-fibre spikes 310 ± 49 315 ± 39
Post-discharge spikes 82 ± 29 133 ± 39
Input spikes 298 ± 59 292 ± 57
Wind up spikes 130 ± 33 233 ± 68
35°C spikes 179 ± 52 102 ± 34
40°C spikes 374 ± 91 263 ± 85
45°C spikes 618 ± 67 693 ± 62
48°C spikes 579 ± 104 513 ± 118
50°C spikes 777 ± 91 888 ± 79
All data are expressed as raw mean values ± SEM. There were no 
significant differences between cells that had the DMSO treatment 
prior to formalin injection or those that were treated with rapamycin 
prior to formalin injection (unpaired t-tests, except for graded 
thermally-evoked responses whereby 2 way ANOVA with 
Bonferroni's post-tests were used).
Table 2: WDR neurones selected for DMSO or anisomycin 
treatment prior to hind paw formalin injection comprised equal 
populations for all measures
DMSO (n = 7) Anisomycin (n = 6)
Depth (μM) 890 ± 85 771 ± 33
Ab-fibre threshold (μA) 0.70 ± 0.04 0.53 ± 0.11
C-fibre threshold (μA) 1.73 ± 0.24 1.64 ± 0.16
Aβ-fibre spikes 224 ± 40 176 ± 29
Aδ-fibre spikes 189 ± 24 145 ± 26
C-fibre spikes 597 ± 79 432 ± 33
Post-discharge spikes 755 ± 113 549 ± 119
Input spikes 576 ± 112 640 ± 128
Wind up spikes 752 ± 86 486 ± 103
35°C spikes 160 ± 50 261 ± 98
40°C spikes 219 ± 49 351 ± 93
45°C spikes 626 ± 148 544 ± 104
48°C spikes 970 ± 145 904 ± 79
50°C spikes 1409 ± 103 1266 ± 97
All data are expressed as raw mean values ± SEM. There were no 
significant differences between cells that had the DMSO treatment 
prior to formalin injection or those that were treated with 
anisomycin prior to formalin injection (unpaired t-tests, except for 
graded thermally-evoked responses whereby 2 way ANOVA with 
Bonferroni's post-tests were used).Page 4 of 10
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also the second phase at 20, 25 and 30 min when com-
pared to DMSO. This was confirmed with AUC analysis
(Figure 3A). The effects of rapamycin were found to be
more selective for licking and biting as there was a signif-
icant reduction in the length of this behaviour in the first
phase at 5 min and also in the second phase at 30 min.
Again, this was confirmed with AUC analysis (Figure 3B).
Rapamycin was however ineffective in attenuating lifting
and flinching behaviour (Figure 3C).
Discussion
These experiments are the first to couple in vivo electro-
physiology with behavioural pharmacology during the
formalin test to show that rapamycin-sensitive mRNA
translation pathways are important in the induction and
maintenance of formalin-induced neuronal excitability
and behavioural hypersensitivity and therefore may also
be important in the induction of clinical persistent pain
and even longer lasting chronic pain states.
Using in vivo electrophysiology to study neuronal
responses from naive rats, we found that rapamycin sig-
nificantly inhibited nociceptive-specific C-fibre-mediated
Effects of spinally administered mRNA translation inhibitors on formalin-induced neuronal hyperexcitabilityFigure 2
Effects of spinally administered mRNA translation inhibitors on formalin-induced neuronal hyperexcitability. 
A. Pooled data of responses from WDR neurones during the formalin test. When rapamycin (n = 9) was administered onto 
the exposed spinal cord 3 min prior to 5% formalin injection into the hind paw, there was significant reduction in neuronal 
activity in the second phase of the test compared to when DMSO (n = 11) was administered to the exposed spinal cord. B. 
Similarly, when the global translation inhibitor anisomycin (n = 7) was administered onto the exposed spinal cord 3 min prior 
to formalin injection into the hind paw there was also a significant reduction in neuronal activity in the second phase of the test 
compared to when DMSO (n = 6) was administered (2 way ANOVA with repeated measures and Bonferroni's post-tests, *P < 
0.05; **P < 0.01).Page 5 of 10
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Effects of spinally administered rapamycin on formalin-induced behavioural hypersensitivityFigure 3
Effects of spinally administered rapamycin on formalin-induced behavioural hypersensitivity. A. When rapamycin 
(n = 6) was administered spinally 20 min prior to 5% formalin injection into the hind paw, there was significant reduction in 
total behavioural hypersensitivity in both the first and second phase of the formalin test compared to when rats were spinally 
pre-treated with DMSO (n = 6). B. Specifically, licking and biting behaviour was attenuated when rats were pre-treated with 
rapamycin. C. Lifting and flinching behaviour however, was unaffected (2 way ANOVA with repeated measures and Bonfer-
roni's post-tests, *P < 0.05, **P < 0.01).
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fibre activity is likely responsible for the accompanying
inhibition of mechanically-evoked responses, yet the
comparatively minor effects on thermally-evoked
responses reveal a selectivity for mechanically-evoked
rather than thermally-evoked responses. The fact that
rapamycin has an effect on baseline neuronal responses
from naive rats suggests that rapamycin-sensitive path-
ways are at least partially important under physiological
conditions. This is perhaps not surprising due to the
involvement of mTOR in other physiological processes
[4].
Using in vivo electrophysiology, we reveal that formalin-
induced neuronal hyperexcitability can be attenuated
when rapamycin is administered spinally as early as 3 min
prior to formalin injection into the hind paw. In behav-
ioural studies, a lumbar injection of rapamycin 5 min
prior to formalin injection did not replicate the results
seen with in vivo electrophysiology. However, behav-
ioural hypersensitivity was attenuated when a 20 min pre-
treatment period was allowed. This could be due to better
access of the drug to its targets in the more static state of
in vivo electrophysiology whereby the drug solution is
placed directly onto the exposed spinal cord (where the
dura is also removed) of the anaesthetised rat or residual
effects of the anaesthetic required for the lumbar injection
in the behavioural testing.
The first phase of the formalin test is believed to reflect the
activity of C-fibre afferent nociceptors, whilst the second
phase of the formalin test is believed to be due to central
sensitisation of dorsal horn neurones within the spinal
cord as a result of the initial barrage of input from C-fibre
nociceptor afferents during the first phase [16-18]. There-
fore, the finding that rapamycin-sensitive pathways are
important in both phases of the formalin test indicates
that central spinal rapamycin-sensitive pathways are
important in both peripherally driven and centrally-medi-
ated aspects of pain processing.
We also hypothesise a role for higher brain regions in
maintaining persistent pain-like states, since rapamycin
that inhibits firing of spinal cord WDR neurones to hind
paw formalin injection is more effective in reducing lick-
ing and biting as opposed to lifting and flinching behav-
iour. According to optimal scoring strategies, licking and
biting has a higher categorical weight than lifting and
flinching [19]. It is logical to hypothesise that lifting and
flinching behaviour could comprise a significant propor-
tion of reflex behaviour whereas licking and biting may
require higher conscious processing (and thus ascending
activity from cord to brain through the dorsal horn neu-
rones) to coordinate different muscle groups by the rat
with the aim of alleviating the behavioural hypersensitiv-
ity. Importantly, the behavioural data confirm that
rapamycin-sensitive pathways are important in formalin-
induced behavioural hypersensitivity thus correlating
with in vivo electrophysiology data where these pathways
are important for formalin-induced neuronal hyperexcita-
bility.
Although the importance of spinal rapamycin-sensitive
pathways in persistent pain-like states has not been exten-
sively studied, there have been reports on the importance
of upstream regulators of mTOR in formalin-induced
inflammation. The role of phosphorylated calcium/cal-
modulin-dependent protein kinase II (CaMKII) and ERK
are two such regulators and these proteins have been
shown to either engage rapamycin-sensitive pathways or
synergise with them, leading to mRNA translation [20-22]
and they are upregulated in the dorsal horn of the spinal
cord after formalin injection into the hind paw [23]. Also
upstream of mTOR is PI3K, which has been recently
shown to be important in formalin-induced behavioural
hypersensitivity [24] and much like CAMKII and ERK,
PI3K has also been shown to engage rapamycin-sensitive
pathways [21,22,25-28].
Further upstream, the action of the neurotransmitter
glutamate on NMDA receptors has been implicated in for-
malin-induced neuronal hyperexcitability [29] and is also
implicated in activation of rapamycin-sensitive pathways
[30,31]. Such is the case with the action of glutamate on
the metabotropic glutamate receptors- mGluR1 and
mGluR5, which is also of importance in formalin-induced
behavioural hypersensitivity [32] as well as activating
rapamycin-sensitive pathways [9,33]. Of particular inter-
est here is the finding by Price et al. who showed that
mGluR5 antagonism failed to reduce formalin-induced
behavioural hypersensitivity in FMR1 mutant mice com-
pared to their wild type littermates, therefore directly
showing the engagement of mRNA translation pathways
by specific receptor activation as a result of formalin-
induced hypersensitivity [9]. Also at the transmitter level,
brain-derived neurotrophic factor (BDNF) acting at Trkb
receptors has been shown to be important in formalin-
induced hypersensitivity [34] and has also separately been
shown to activate rapamycin-sensitive pathways
[27,28,35,36]. It is therefore clear that a plethora of cen-
tral neurotransmitters, receptors and subcellular mole-
cules that are important in pain processing likely act via
mTOR, implicating rapamycin-sensitive pathways as key
mediators of induction as well as maintenance of persist-
ent pain-like states. We hypothesise that not only is mTOR
a key regulator of mRNA translation, but that mTOR-
dependent mRNA translation is at the root of the neuro-
nal changes and thus the behaviour associated with per-
sistent and chronic pain states.Page 7 of 10
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Animals
For all studies, male Sprague Dawley rats (250 – 280 g)
were used. These were supplied by the Biological Services
Unit (BSU, University College London, UK). All proce-
dures were carried out in accordance the UK Animals (Sci-
entific Procedures) Act, 1986 and were in agreement with
the IASP guidelines [37].
In vivo electrophysiology
In vivo electrophysiology studies were carried out accord-
ing to a well established protocol [38]. Rats were initially
anaesthetised in an induction box with 4% isofluorane in
a mixture of nitrous oxide (66% v/v) and oxygen (33% v/
v). Once the rats had lost consciousness and were com-
pletely areflexic, the trachea was exposed and isolated and
a cannula was inserted into the trachea and fastened with
3-0 silk threads. This was used to maintain anaesthesia
throughout the recording period. At this stage, the iso-
fluorane was reduced to 2.5% v/v (areflexia was main-
tained). Rats were then secured in a stereotaxic frame and
a rectal probe attached to a heating blanket was used to
maintain a core temperature of 37°C.
An incision was made through the skin along the length
of vertebrae and the skin was then separated from the
underlying muscle. Muscle, connective tissue and verte-
brae were specifically removed from lumbar vertebral seg-
ments L1 – L3 of the spinal cord. Muscle and connective
tissue from surrounding areas were kept intact and this
created a well in the exposed spinal cord area into which,
drug solutions could be added. Clamps were used to sta-
bilise and straighten the cord. The dura mater was also
removed to aid drug penetration. When the set up was
complete, the isofluorane was reduced to 1.8% v/v, a level
sufficient for anaesthesia, whilst maintaining areflexia.
11.43 ng rapamycin (sirolimus, LC laboratories) dis-
solved in a 50 μl saline/dimethyl sulphoxide (DMSO,
Sigma) mix comprising 25% v/v DMSO (250 nM rapamy-
cin); 62.35 μg anisomycin (Sigma) dissolved in a in a 50
μl saline/DMSO mix comprising 10% v/v DMSO (4.7 mM
anisomycin); 25% v/v DMSO and 10% v/v DMSO were
applied directly onto the exposed spinal cord.
Recordings were obtained with an AC recording system
(NeuroLog system, Digitimer). An electrode (parylene
insulated tungsten microelectrode, 125 μm diameter, 2
MΩ, A-M systems Inc.) inserted into a head stage attached
to a 3-axis manipulator was manually lowered into the
exposed cord (L4 – L5) to a depth of 500 – 1000 μM. This
is an area occupied by WDR neurones that are important
in pain processing. An oscilloscope was used to isolate
single neurones and a number of stimuli were applied to
the receptive field. Mechanical stimuli (von Frey fila-
ments) were applied to the most sensitive part of the
receptive field for 10 s. This was also the case for thermal
stimuli, where increasing heat was applied using a jet of
water from a 60 ml syringe attached to a needle.
Before formalin was administered to the hind paw, a neu-
rone was selected and characterised. Electrical stimuli
were delivered by inserting two stimulating electrodes
intradermally into the most sensitive part of the receptive
field of the hind paw. Firstly, Aβ- and C-fibre thresholds
were determined depending on their latencies to respond
to stimuli (Aβ-fibres = <20 ms post-stimulus; C-fibres = 90
– 300 ms post-stimulus). The stimulator was then set to
three times C-fibre threshold and a train of 16 stimuli (0.5
Hz, 2 ms pulse width) was delivered to the receptive field
to determine the number of action potentials attributable
to Aβ-fibres (0 – 20 ms); Aδ-fibres (20 – 90 ms); C-fibres
(90 – 300 ms) and post-discharge (300 – 800 ms) which
is attributable to the wind up elicited by repeated stimuli
of nociceptive C-fibres. The input (non-potentiated
response) and the wind up (potentiated response) were
calculated as follows: C-fibre Input = action potentials (90
– 800 ms) evoked by the first pulse at three times C-fibre
threshold multiplied by the total number of pulses (16).
This represents the theoretical baseline in the absence of
wind up. Wind up = total action potentials (90 – 800 ms)
after the 16-train stimulus at three times C-fibre threshold
minus the input. This represents the excess activity above
the theoretical baseline due to wind up. For characterising
thermally-evoked responses prior to hind paw formalin
injection, increasing heat was applied using a water jet
directed at the receptive field for 10 s. When determining
the effect of rapamycin on baseline neuronal responses,
only stable cells where 3 consecutive stimulus-evoked
responses that were within 10% of the previous result for
the same test were selected for further pharmacological
study. A 'test' comprising electrical, mechanical and ther-
mal stimuli was carried out every 20 min. Maximum
changes (positive or negative) from control in neuronal
activity were used for data analysis (all raw values).
To monitor spontaneous neuronal activity as a result of
formalin-induced inflammation, 50 μl of a 5% v/v forma-
lin solution made from 40% v/v formaldehyde solution
(BDH Chemicals Ltd) was intradermally injected into the
hind paw ipsilateral to the WDR neurone which had
already been characterised, using a 0.5 ml insulin syringe
(BD Micro-Fine™). A WDR neurone was selected on one
side of the cord for treatment with spinally administered
(intrathecal or i.t.) vehicle prior to formalin injection into
the corresponding hind paw. Only after a biphasic control
response was achieved was a neurone then selected on the
opposite side for treatment with the drug prior to forma-
lin injection into the corresponding hind paw. Neuronal
activity was separated into bins of 10 min.Page 8 of 10
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Before each behavioural study, each rat was allowed to
acclimatise for 30 min in individual open top clear Plex-
iglass chambers (length, width, height = 25 × 25 × 25 cm).
In order to determine the effect of drugs at the spinal level
on pain-like behaviour, rats were first lightly anaesthe-
tised on 2% v/v isofluorane in a mixture of nitrous oxide
(50% v/v) and oxygen (50% v/v) after which they were
disinfected and lightly shaved across their backs. A 0.5 ml
insulin syringe (BD Micro-Fine™) was used to inject a 20
μl i.t. dose of drug solution (250 μM or 11.43 μg in a 50
μl saline/DMSO mix comprising 25% v/v DMSO)
through the skin, into the L5 – L6 vertebral interspace
after which, the rats were allowed to recover prior to for-
malin injection into the hind paw. A 20 μl volume has
been shown to produce uniform coverage of the spinal
cord which is restricted to the sacral and cauda equina lev-
els and extends up to thoracic T13 – lumbar L1 [39].
Behavioural studies used a higher dose of drug (250 μM)
compared with electrophysiological studies (250 nM)
since 250 μM rapamycin has been shown to be effective in
attenuating capsaicin- and nerve-injury-induced behav-
ioural hypersensitivity when injected locally into the hind
paw [6]. After the rats had recovered, they were restrained
and 5% v/v formalin solution was then administered to
the left hind paw. The rats were then placed back into their
chambers and observed for 1 hr. The following behav-
iours were measured: 1) licking and biting and 2) lifting
and flinching [40]. Behavioural data were separated into
bins of 5 min. The drug regimen was blinded until the
analysis was complete.
After all studies, rats were overdosed on a rising concen-
tration of CO2, after which, death was ensured by cervical
dislocation of the neck.
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